Imunon, Inc. Other Preferred Stock Dividends and Adjustments
Imunon, Inc. (IMNN) reported Other Preferred Stock Dividends and Adjustments of $4.60 million for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherPreferredStockDividendsAndAdjustments · last filed 2016-03-30
- Imunon, Inc. other preferred stock dividends and adjustments for the quarter ending 2013-12-31 was $0.00.
- Imunon, Inc. other preferred stock dividends and adjustments for the quarter ending 2013-09-30 was $0.00.
- Imunon, Inc. other preferred stock dividends and adjustments for the quarter ending 2013-06-30 was $9.20M.
- Imunon, Inc. other preferred stock dividends and adjustments for the quarter ending 2013-03-31 was -$4.60M.
- Imunon, Inc. other preferred stock dividends and adjustments for fiscal 2013 was $4.60M.
| Period end | Other Preferred Stock Dividends and Adjustments 3 month | Other Preferred Stock Dividends and Adjustments 6 month | Other Preferred Stock Dividends and Adjustments 9 month | Other Preferred Stock Dividends and Adjustments 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $0.00 derived: sum of 2 quarters · filed 2016-03-30 | $9.20M derived: sum of 3 quarters · filed 2016-03-30 | $4.60M 10-K · filed 2016-03-30 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $9.20M derived: sum of 2 quarters · filed 2014-11-10 | $4.60M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $9.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $4.60M 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$4.60M 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |